Cargando…
Progress of small molecular inhibitors in the development of anti-influenza virus agents
The influenza pandemic is a major threat to human health, and highly aggressive strains such as H1N1, H5N1 and H7N9 have emphasized the need for therapeutic strategies to combat these pathogens. Influenza anti-viral agents, especially active small molecular inhibitors play important roles in control...
Autores principales: | Wu, Xiaoai, Wu, Xiuli, Sun, Qizheng, Zhang, Chunhui, Yang, Shengyong, Li, Lin, Jia, Zhiyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381247/ https://www.ncbi.nlm.nih.gov/pubmed/28382157 http://dx.doi.org/10.7150/thno.17071 |
Ejemplares similares
-
Recent Progress of Imaging Agents for Parkinson's Disease
por: Wu, Xiaoai, et al.
Publicado: (2014) -
Small Molecule Inhibitors of Influenza Virus Entry
por: Chen, Zhaoyu, et al.
Publicado: (2021) -
Identification of Nifurtimox and Chrysin as Anti-Influenza Virus Agents by Clinical Transcriptome Signature Reversion
por: Xin, Yijing, et al.
Publicado: (2022) -
Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years
por: Ju, Zhiran, et al.
Publicado: (2022) -
Resistance to anti-influenza agents
por: Guan, Yi, et al.
Publicado: (2005)